And there are lingering concerns about the possible (albeit extremely low) risk of thyroid cancer from taking Ozempic, ...
Johnson & Johnson announced the submission of regulatory applications to the U.S. FDA and European Medicines Agency seeking approval of a ...
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
The safety results from the EoE KIDS study were consistent with the known safety profile of Dupixent in adolescents and ...
For those with lupus, Botox has a heightened risk of side effects. It can also interact with your lupus medications, so it's best to discuss with your doctor first.
In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...
BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...
Praxis recognized $0.3 million in collaboration revenue during the three months ended September 30, 2024, compared to $0.5 million during the three months ended September 30, 2023. The decrease of ...
Anavex Life Sciences' (AVXL) stock surged on new Alzheimer's trial data, but data's inconsistency raises concerns, making the ...
The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback